Results 1 to 10 of about 2,712,287 (341)

Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

open access: yesFrontiers in Pain Research, 2021
Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individual and socioeconomic outcomes. Chronic migraine is defined as headaches occurring on at least 15 days per month with at least eight of these fulfilling ...
Tiffani J. Mungoven   +2 more
doaj   +2 more sources

Management of chronic migraine

open access: yesBMJ, 2022
Chronic migraine is a neurologic disorder associated with considerable disability, lost productivity, and a profound economic burden worldwide. The past five years have seen a dramatic expansion in new treatments for this often challenging condition ...
A. Hovaguimian, Julie Roth
semanticscholar   +3 more sources

Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review

open access: yesEuropean Journal of Medical Research, 2022
Background Resistant chronic migraine is a highly disabling condition which is very difficult to treat. The majority of the treatments for migraine prophylaxis are nonspecific and present weak safety profiles, leading to low adherence and discontinuation.
Hugo Sevivas, Paula Fresco
doaj   +2 more sources

The Chronic Migraine Brain: What Have We Learned From Neuroimaging?

open access: yesFrontiers in Neurology, 2020
Chronic migraine is a highly disabling disease with a great impact on socioeconomic functioning and quality of life of migraine patients. Chronic migraine usually evolves from episodic migraine that gradually increases in attack frequency, supporting the
Massimo Filippi   +4 more
doaj   +2 more sources

Current and emerging evidence-based treatment options in chronic migraine: a narrative review

open access: yesThe Journal of Headache and Pain, 2019
Background Chronic migraine is a disabling condition that is currently underdiagnosed and undertreated. In this narrative review, we discuss the future of chronic migraine management in relation to recent progress in evidence-based pharmacological ...
Elio Clemente Agostoni   +15 more
doaj   +2 more sources

Offset analgesia as a marker of dysfunctional pain modulation in episodic and chronic migraine. [PDF]

open access: yesJ Headache Pain
Background The offset analgesia phenomenon refers to the disproportionately large decrease in the perceived pain following a slight decrease in intensity of a noxious heat stimulus.
Cosentino G   +8 more
europepmc   +2 more sources

IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine

open access: yesThe Journal of Headache and Pain, 2022
Background Chronic migraine places a disabling burden on patients, which is extensively modeled by the nitroglycerin (NTG)-treated animal model. Although the NF-κB pathway is involved in an increase in CGRP levels and activation of the trigeminal system ...
Hao Chen   +7 more
semanticscholar   +1 more source

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score

open access: yesCNS Drugs, 2022
Criteria, including clinical features and effective outcomes, for access and persistence of novel but costly treatments may vary between countries, thus affecting the health of patients.
L. Iannone   +5 more
semanticscholar   +1 more source

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

open access: yesThe Journal of Headache and Pain, 2022
Background Clinical trials have shown that erenumab is effective and well-tolerated for the preventive treatment of chronic migraine. To extend the results from clinical trials, we assessed the real-world efficacy and safety of erenumab in patients with ...
C. K. Cullum   +10 more
semanticscholar   +1 more source

A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine

open access: yesThe Journal of Headache and Pain, 2022
Background and aims Chronic migraine is a common neurovascular brain disorder with substantial economic costs. We performed a systematic review to identify economic evaluations of pharmacological treatments for adults with chronic migraine.
S. Khanal   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy